InsidersTradesSigma
Track the Senzime AB share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Senzime AB has logged 0 insider filings. Market capitalisation: €566m. Every trade is free.
Analysts rate Senzime AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 10.50.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
Senzime AB is a company focused on developing patient monitoring solutions in the healthcare sector. It is listed on the XSTO stock exchange.